Last reviewed · How we verify
NCT06614673: CLARO
Cancer Literacy as an Essential Factor for Lifestyle Behavior Changes: An Observational and Interventional Study
NA trial testing text in non-narrative form in Cancer Prevention in 1,422 participants. Completed in 31 May 2025.
31 May 2025
Quick facts
| Lead sponsor | German Cancer Research Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 1,422 |
| Start date | 30 January 2025 |
| Primary completion | 31 May 2025 |
| Estimated completion | 31 May 2025 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- text in non-narrative form
- text in narrative form
- animated video in non-narrative form
- animated video in narrative form
Conditions studied
- Cancer Prevention — all drugs for Cancer Prevention →
Sponsor
German Cancer Research Center — full company profile →
Who can join
Adults 18 to 70, any sex, with Cancer Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The CLARO study aims to examine the most effective way to design information materials that can strengthen optimistic beliefs about cancer prevention and improve cancer literacy indirectly. Around 5,800 participants from the Stuttgart region in Germany will be contacted by postal mail and invited to take part in an online survey using the LimeSurvey®-System. Four different types of information materials, tested in a pilot study (2x2-design: text or animation-based / narrative or non-narrative), will be included in the survey. Participants will be randomly assigned to one of the four interventions or to a control group that will not receive any intervention (the control group will have access to all information materials after having completed the whole questionnaire). As an incentive, participants will receive 10€ via bank transfer upon completing the survey.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06614673
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of text in non-narrative form
Trials testing the same drug.
- NCT06026384 — Evaluation of Text or Animation-based Narrative and Non-narrative Interventions to Enhance Cancer Literacy: a Pilot Stud · NA · completed
Other recruiting trials for Cancer Prevention
Currently open trials in the same condition.
- NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
- NCT07225881 — Eatwell Clinical Trial (R01) · NA · recruiting
- NCT07501689 — Using Middle School Science Teachers to Address Cancer Health Disparities · NA · recruiting
- NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
- NCT06421324 — Personalised Health Recommendations to the General Population Through an Integrated AI Guided · NA · recruiting
Other German Cancer Research Center trials
Trials by the same sponsor.
- NCT06026384 — Evaluation of Text or Animation-based Narrative and Non-narrative Interventions to Enhance Cancer Literacy: a Pilot Stud · NA · completed
- NCT05999396 — FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer · Phase 1 · recruiting
- NCT05494866 — A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal · Phase 1 · terminated
- NCT06621810 — Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults · recruiting
- NCT04410653 — Afatinib in Advanced NRG1-Rearranged Malignancies · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06614673 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by German Cancer Research Center
- Last refreshed: 15 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06614673.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing